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Abstract
BACKGROUND: Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders of women 
in the childbearing period. However, its pathophysiology is still unclear. Certain polymorphisms of the luteinizing 
hormone/choriogonadotropin receptor (LHCGR) genes may lead to changes in the bioactivity of this hormone. The 
important functional role of LHCGR in the metabolism of androgen and ovulation, the LHCGR gene variant, may be 
related to the risk of PCOS.
AIM: The aim of this study was to evaluate the association between LHCGR Ins18LQ gene polymorphism and PCOS.
METHODS: A case–control study was performed in women with PCOS and non-PCOS from May 2019 to October 
2019 in HFC IVF Center. We included 50 women with PCOS and 50 healthy controls. Polymorphism of the LHCGR 
(ins18LQ) gene was genotyped using polymerase chain reaction-restriction fragment length polymorphism.
RESULTS: From this study, we found that there was no significant difference in the proportion of ages between 
the groups (p > 0.05). There were significant differences in the characteristics of body mass index, FSH level, LH 
level, and LH/FSH ratio between the PCOS and control groups (p < 0.05). We also found that the proportion of 
heterozygote variant non-ins/ins was higher in the PCOS group compared to the control group, but there was no 
significant difference between the polymorphisms of the non-ins and non-nonins variants between the PCOS and 
control groups (p = 0.269). The frequency of ins alleles was higher in the PCOS group compared to the control group.
CONCLUSION: There was no significant association between LHCGR ins18LQ gene polymorphism and PCOS.
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Introduction
Polycystic ovary syndrome (PCOS) is one 
of the most common ovulatory disorders, affecting 
5–10% of women of reproductive age. This is 
characterized by the failure of the ovaries, polycystic 
ovaries, and excess production of androgens, which 
can cause infertility [1], [2]. Nowadays, the etiology 
of PCOS is still unclear. Some due to genetic and 
hormonal factors affecting the pathogenesis of 
PCOS include alteration of ovarian steroid synthesis, 
hyperinsulinemia, impaired folliculogenesis, 
abnormalities in gonadotropin, and neuroendocrine 
secretions [3], [4], [5].
Some studies showed that genetic factors 
are very important in the development of PCOS. The 
study on genes susceptible to PCOS has focused 
mainly on gene polymorphisms that encode sex 
hormones and regulatory proteins such as follicle-
stimulating hormone ß, follicle-stimulating hormone 
receptor, luteinizing hormone/choriogonadotropin 
receptor (LHCGR), estrogen receptor alpha-
receptor (ESR1), and estrogen receptor ß (ESR2). 
Variants of genetic markers have implications for 
the predisposition of PCOS; however, there are no 
variants that are directly and repeatedly linked to 
PCOS [3], [6].
Several single nucleotide polymorphisms can 
change the expression of genes or the function of 
the LHCGR protein, which has been identified in the 
LHCGR gene. Given the important functional role of 
LHCGR in androgen metabolism and ovulation, the 
LHCGR gene variant may be associated with the risk of 
PCOS [3], [6], [7], [8].
Chen et al. conducting a genome-wide 
association study SOPK in Han Chinese women found 
evidence of a strong association between PCOS and 
the LHR gene locus [9].
The aim of this study was to evaluate 
the association between LHCGR Ins18LQ gene 
polymorphism and PCOS.
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Materials and Methods
This case–control study included 100 unrelated 
women: 50 women with PCOS and 50 healthy women 
with regular menses and ultrasonographically normal 
ovaries from May 2019 to October 2019 in Halim Fertility 
Center, Division of Reproductive Endocrinology and 
Infertility, Department of Obstetrics and Gynecology, 
Faculty of Medicine, Universitas Sumatera Utara, Haji 
Adam Malik General Hospital, Medan, Indonesia. The 
diagnosis of PCOS was based on the 2004 revised 
Rotterdam criteria (24). At least two of the following 
three features needed to be present: (1) Oligo-ovulation 
or anovulation (<6 menstrual periods per year); (2) 
clinical and/or biochemical signs of hyperandrogenism, 
including hirsutism (Ferriman–Gallwey score>8) and/or 
total testosterone level >0.8 ng/mL; and (3) sonographic 
evidence of PCOS. Other causes of oligomenorrhea 
were excluded in patients with PCOS.
All women underwent a complete history, 
including cycle length and a thorough clinical 
examination. All women were not in pregnancy and 
did not use oral contraception in the last 3 months. 
We assessed clinical and anthropometrical variables, 
including body mass index (BMI) in all participants. 
Exclusion criteria for all women included a history of 
hyperandrogenic states (such as non-classic congenital 
adrenal hyperplasia, androgen-secreting tumors, 
Cushing’s syndrome, 21-hydroxylase deficiency, or 
hyperprolactinemia), diabetes mellitus, hypertension, 
liver, kidney, or thyroid diseases.
Biochemical measurements
Blood samples were drawn from all subjects 
during the early follicular phase of the menstrual cycles. 
We took that blood sample 3 cc of whole blood was 
collected into tubes containing EDTA for determination 
of DNA isolation.
DNA extraction
Genomic DNA was extracted from EDTA whole 
blood using a spin-column method according to the 
protocol (Promega). DNA was stored at ‒20°C till the 
time of use.
Genotyping of LHCGR genes 
polymorphisms
Genotyping for the ins18LQ (rs4539842) in 
exon one genes polymorphisms was performed by a 
polymerase chain reaction-restriction fragment length 
polymorphism method. The PCR protocols of LHCGR 
ins18LQ were performed with the following settings: 
94°C for 5 min, followed by 35 cycles at 94°C for 30 s, 
56°C of LHCGR ins18LQ for 30 s, and 72°C for 45 s. 
A final extension step was carried out at 72°C for 
7 min. All PCR products were digested with restriction 
enzymes according to the manufacturer’s instruction. 
The fragments were resolved by gel electrophoresis in 
a 2% agarose gel stained with ethidium bromide 1.0 µL 
and visualized under a UV transilluminator. A 50-bp 
ladder was used as a marker. PCR primer sequence, 
restriction enzyme, and fragments size are listed 
(Table 1). Notably, 10% of the samples were amplified 
twice for checking the accuracy of the results.
Table 1: PCR primer sequence, restriction enzyme, and 
fragment size for the detection of LHCGR gene polymorphism
SNP locus PCR primer sequence Restriction 
enzyme
Fragment Size
LHCGR 
ins18LQ
F:5’-
GACACTGGCAAGCCGCAGAAGCCC-3’ 
R:5’-
GCTGTGTACTCACAGTCGAGTGAG-3’
PvuII non-ins allele: 65 
+149 bp
ins allele: 
65+27+128 bp
SNP: Single-nucleotide polymorphisms.
Statistical analysis
Data were analyzed by computer applications 
in accordance with comparative analytical data 
presentation. Data were expressed using descriptive 
statistics (mean ± standard deviation) and were 
analyzed using the test. To analyze the association 
between LHCGR Ins 18 LQ and PCOS group, we used 
a one-way analysis of variance test to compare different 
parameters. p < 0.05 was considered statistically 
significant. Genotype frequencies in cases and controls 
were tested for Hardy–Weinberg equilibrium and 
any deviation between the observed and expected 
frequencies were tested for significance. The statistical 
analysis was performed using SPSS 17.0.
Results
During the study period, 100 subjects were 
included in the analysis. The patient demographics, 
age of women, BMI, FSH level, LH level, and LH/FSH 
ratio are depicted in Table 2. From Table 2, we found 
that there was no significant difference between the 
PCOS group and the control group in the age of women 
(p > 0.05). We also found that BMI in women with 
Table 2: Distribution of characteristics of PCOS and control 
groups
Characteristics PCOS Controls p-value
n = 50 n = 50
Age (mean ± SD) 29.5 ± 3.6 31.2 ± 4.24
>30 yo (n %) 19 (38) 29 (58) 0.361a
≤30 yo (n %) 31 (62) 21 (42)
Body mass index (kg/m2), (mean ± SD) 26.4 ± 4.61 24.23 ± 2.93 0.019b
Underweight (<18.5) (n%) 1 (2) 2 (4)
Normal weight (18.5 – 24.9) (n%) 21 (42) 30 (60)
Overweight (25 – 29.9) (n%) 19 (38) 16 (32)
Obese (≥30) (n%) 9 (18) 2 (4)
FSH, (Mean ± SD) 5.07 ± 1.19 5.94 ±1.89 0.008c
LH, (Mean ± SD) 10.97 ± 8.34 3.63 ±1.57 <0.001c
LH/FSH ratio, (Mean ± SD) 2.10 ± 1.16 0.65 ± 0.31 <0.001c
aChi-square, bKruskal Wallis, cT Independent.
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PCOS was higher than controls (p < 0.05). FSH level 
in the PCOS group was lower than the control group, 
and there was a significant difference between them 
(p < 0.05). We also found that the LH level and LH/FSH 
ratio in the PCOS group was higher than the control 
group, and there was a significant difference between 
them (p < 0.05).
From Table 3, the proportion of wild-type non-
ins/non-ins homozygote genotypes in the PCOS group 
was lower than the control group with a proportion of 
88% versus 96%. Meanwhile, for the proportion of 
heterozygote variant non-ins/ins, in the PCOS group, 
there were six women (12%), while in the control group, 
there were only two women (4%). No homozygote 
mutant ins/ins genotypes were found in the two groups. 
The frequency of non-ins allele in the PCOS group was 
94%, lower than the control group with a proportion of 
98%. The frequency of ins alleles in the PCOS group 
was higher than in the control group (6% vs. 2%). There 
was no significant difference in LHCGR ins18LQ gene 
polymorphism between PCOS and controls (p > 0.05).
Discussion
PCOS is one of the most common ovulatory 
disorders, affecting 5–10% of women of reproductive 
age [3], [10], [11], [12], [13]. Recently, many studies 
suggested that genetic factors were strongly associated 
with the etiology of PCOS [2], [3], [10], [11], [12], [13]. 
However, only a few genes were found to have an 
association with PCOS or some clinical traits related 
to PCOS. Until now, the relationship between the LH 
signaling pathway and PCOS has not been defined 
clearly [3], [11], [12], [13].
From this study, we found that BMI in women 
with PCOS was higher than women without PCOS 
and there was a significant difference between them 
(p < 0.05). Elshal et al. and Gambineri et al. also found 
that the majority of patients with PCOS had obese BMI 
(77.1%) [3], [14]. The results of this study are also in 
accordance with the research of Thathapudi et al. which 
reported that there was a significant difference between 
BMI in PCOS and controls (p < 0.05), where BMI in 
PCOS was higher than in controls [8].
In this study, we found that the FSH level in 
the PCOS group was lower than the control and there 
was a significant difference between them (p < 0.05). 
Then, we also found that the LH level and LH/FSH ratio 
in the PCOS group was higher than the control group, 
and there was significant difference between them 
(p < 0.05). Similar to our data, Thathapudi et al. also 
found that LH level and LH/FSH ratio was higher in the 
PCOS group than control group (p < 0.05) [8]. 
In this study, there was no significant difference 
in LHCGR Ins18LQ gene polymorphism between PCOS 
and Control groups with p > 0.05. In the LHCGR ins 
18LQ gene polymorphism, no significant relationship 
was found between the polymorphisms of the non-
ins and non-nonins variants between the PCOS and 
control groups (p > 0.05). In LHCGR ins18LQ gene 
polymorphism, the results of this study are in line with 
research by Elshal et al. and Liu et al., where they did 
not find a meaningful relationship between LHCGR ins 
18LQ polymorphisms with PCOS in Egyptian women 
and Chines Han [3], [11]. However, this is different from 
the study by Valkenburg et al. who found that the 18ins 
LQ insertion allele frequency was significantly lower in 
Caucasian PCOS women than controls [15].
Conclusion
There was no significant association between 
LHCGR ins18LQ gene polymorphism and PCOS.
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